Medifast, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $301.6M | $274.5M | $272.8M | $285.3M | $324.1M | $318.6M | $298.2M | $257.6M |
| Cost of Revenue | $73.8M | $68.9M | $71.5M | $76.1M | $83.5M | $82.7M | $73.7M | $65.1M |
| Gross Profit | $227.8M | $205.7M | $201.3M | $209.2M | $240.6M | $235.9M | $224.5M | $192.5M |
| Gross Margin | 75.5% | 74.9% | 73.8% | 73.3% | 74.2% | 74.1% | 75.3% | 74.7% |
| Operating Expenses | ||||||||
| Research & Development | $1.5M | $2.0M | $1.8M | $1.3M | — | — | — | — |
| SG&A Expense | $188.2M | $178.8M | $172.6M | $179.0M | $202.2M | $208.8M | $197.1M | $160.8M |
| Operating Income | $39.6M | $26.9M | $28.7M | $30.2M | $38.4M | $27.1M | $27.4M | $31.6M |
| Operating Margin | 13.1% | 9.8% | 10.5% | 10.6% | 11.9% | 8.5% | 9.2% | 12.3% |
| Interest Expense | — | — | — | — | $12.0K | $62.0K | $102.0K | $111.0K |
| Pretax Income | $40.3M | $27.1M | $29.7M | $31.7M | $39.0M | $28.4M | $27.7M | $31.7M |
| Income Tax Expense | $12.6M | $9.3M | $10.1M | $10.7M | $11.9M | $9.9M | $9.1M | $12.1M |
| Net Income | $27.7M | $17.8M | $20.1M | $13.2M | $24.0M | $15.9M | $18.5M | $19.6M |
| Net Margin | 9.2% | 6.5% | 7.4% | 4.6% | 7.4% | 5.0% | 6.2% | 7.6% |
| EPS (Basic) | $2.32 | $1.51 | $1.68 | $1.04 | $1.74 | $1.16 | $1.33 | $1.39 |
| EPS (Diluted) | $2.29 | $1.49 | $1.66 | $1.03 | $1.73 | $1.16 | $1.31 | $1.35 |
| Shares Outstanding (Basic) | 11.9M | 11.8M | 12.0M | 12.7M | 13.8M | 13.7M | 14.0M | 14.1M |
| Shares Outstanding (Diluted) | 12.1M | 11.9M | 12.1M | 12.8M | 13.8M | 13.7M | 14.2M | 14.6M |
| Dividends Per Share | $1.44 | $1.07 | $0.25 | $0.00 | $0.00 | — | — | — |